These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16965576)

  • 1. Antibodies against glutathione S-transferase T1 in non-solid organ transplanted patients.
    Wichmann I; Aguilera I; Sousa JM; Bernardos A; García Núñez EJ; Vigil E; Magariño R; Magariño I; Torres A; Núñez-Roldán A
    Transfusion; 2006 Sep; 46(9):1505-9. PubMed ID: 16965576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloimmune response against donor glutathione S-transferase T1 antigen in renal transplant recipients.
    Aguilera I; Wichmann I; Gentil MA; Gonzalez-Escribano F; Nuñez-Roldan A
    Am J Kidney Dis; 2005 Aug; 46(2):345-50. PubMed ID: 16112055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against the donor antigen glutathione S-transferase T1 after renal transplantation.
    Aguilera I; Wichmann I; Gentil MA; Gonzalez-Escribano F; Nuñez-Roldan A
    Transplant Proc; 2005 Apr; 37(3):1457-8. PubMed ID: 15866637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of glutathione S-transferase T1 donor/recipient mismatch and anti-GSTT1 antibodies in hepatic graft-versus-host-disease.
    Martínez-Bravo MJ; Tallón I; Espigado I; Perez-Simón JA; Pérez-Romero P; Gracia-Ahufinger I; Aguilera I; Núñez-Roldán A
    Immunol Lett; 2011 Dec; 141(1):140-4. PubMed ID: 21968078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation.
    Salcedo M; Rodríguez-Mahou M; Rodríguez-Sainz C; Rincón D; Alvarez E; Vicario JL; Catalina MV; Matilla A; Ripoll C; Clemente G; Bañares R
    Liver Transpl; 2009 May; 15(5):530-9. PubMed ID: 19399747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation.
    Aguilera I; Sousa JM; Gavilán F; Bernardos A; Wichmann I; Nuñez-Roldán A
    Liver Transpl; 2004 Sep; 10(9):1166-72. PubMed ID: 15350010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with GSTT1 null genotype as prognostic marker: long-term follow-up after liver transplantation.
    Rodriguez-Mahou M; Salcedo M; Fernandez-Cruz E; Tiscar JL; Bañares R; Clemente G; Vicario JL; Alvarez E; Rodriguez-Sainz C
    Transplantation; 2007 Apr; 83(8):1126-9. PubMed ID: 17452905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase T1 genetic mismatch is a risk factor for de novo immune hepatitis in liver transplantation.
    Aguilera I; Sousa JM; Gavilan F; Bernardos A; Wichmann I; Nuñez-Roldan A
    Transplant Proc; 2005 Nov; 37(9):3968-9. PubMed ID: 16386599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of GSTT1 mismatch in solid organ and hematopoietic stem cell transplantation.
    Aguilera I; Sousa JM; Núñez-Roldán A
    Hum Immunol; 2013 Nov; 74(11):1470-3. PubMed ID: 23792056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione S-transferase T1-null seems to be associated with graft failure in hematopoietic SCT.
    Elhasid R; Krivoy N; Rowe JM; Sprecher E; Efrati E
    Bone Marrow Transplant; 2010 Dec; 45(12):1728-31. PubMed ID: 20348973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation.
    Aguilera I; Sousa JM; Praena JM; Gómez-Bravo MA; Núñez-Roldan A
    Clin Transplant; 2011; 25(2):207-12. PubMed ID: 20236132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation.
    Aguilera I; Wichmann I; Sousa JM; Bernardos A; Franco E; García-Lozano JR; Núñez-Roldán A
    Clin Exp Immunol; 2001 Dec; 126(3):535-9. PubMed ID: 11737073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
    Ardesjö B; Hansson CM; Bruder CE; Rorsman F; Betterle C; Dumanski JP; Kämpe O; Ekwall O
    J Autoimmun; 2008 Jun; 30(4):273-82. PubMed ID: 18242955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of glutathione S-transferase T1 gene polymorphisms on acute cellular rejection in living donor liver transplantation.
    Kamei H; Masuda S; Nakamura T; Fujimoto Y; Oike F; Ogura Y; Takada Y; Hamajima N
    Transpl Immunol; 2013 Jan; 28(1):14-7. PubMed ID: 23153768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo recipient-specific Glutathione S-transferase T1 antibody development after HLA-identical hematopoietic cell transplantation.
    Martínez-Bravo MJ; Sánchez B; Acevedo MJ; Pérez-Simón JA; Núñez-Roldán A; Aguilera I
    Transpl Immunol; 2018 Feb; 46():36-41. PubMed ID: 29246878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis.
    Aguilera I; Sousa JM; Gavilan F; Gomez L; Alvarez-Márquez A; Núñez-Roldán A
    Liver Transpl; 2011 Jul; 17(7):779-88. PubMed ID: 21425430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.